Skip to main content
. 2022 Mar 22;9:848499. doi: 10.3389/fcvm.2022.848499

Figure 8.

Figure 8

Combined efficacies of post-PCI QFR, %QFR increase and deceleration capacity for risk stratification in patients with NSTE-ACS.